Could the incidence of healthcare infections in Europe simply be a reflection of overall quality standards?

Journal of Hospital Infection

Volumn 82, Issue 3, 2012, Pages 141-142

  Borg, Michael A ^a  

^a MATER DEI HOSPITAL   (Malta)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT;

CATARACT; CONFIDENCE INTERVAL; CORRELATION ANALYSIS; DIALYSIS; DISEASE CONTROL; EUROPE; HEALTH CARE; HEALTH CARE QUALITY; HEALTHCARE ASSOCIATED INFECTION; HUMAN; INCIDENCE; KIDNEY GRAFT; MAMMOGRAPHY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MORTALITY; NONHUMAN; NOTE; PREVALENCE; SMOKING; STAPHYLOCOCCUS AUREUS;

CROSS INFECTION; DELIVERY OF HEALTH CARE; EUROPE; HUMANS; INCIDENCE; INFECTION CONTROL;

EID: 84867724308     PISSN: 01956701     EISSN: 15322939     Source Type: Journal    
DOI: 10.1016/j.jhin.2012.07.016     Document Type: Note

References (5)

1. Pittet D. Infection control and quality health care in the new millennium. Am J Infect Control 2005, 33:258-267.
2. Antimicrobial resistance surveillance in Europe 2010. Annual Report of the European Antimicrobial Resistance Surveillance Network (EARS-Net) 2011, European Centre for Disease Prevention and Control, ECDC, Stockholm. 10.2900/14911.
3. Euro Health Consumer Index 2012 Report 2012, Health Consumer Powerhouse AB, Stockholm.
4. Borg M.A. Are healthcare economics a factor behind European MRSA rates?. Eur J Clin Microbiol Infect Dis 2010, 29:477-479.
5. Borg M.A., Camilleri L., Waisfisz B. Understanding the epidemiology of MRSA in Europe: do we need to think outside the box?. J Hosp Infect 2012, 81:251-256.